Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Role of interleukin-13 in the pathogenesis of eosinophilic esophagitis

May 31, 2005

Santarus submits Zegerid chewable tablets NDA

May 31, 2005

Blocking cathepsins alleviates experimental colitis / News in Context

May 30, 2005

Novel therapeutic agents for gastrointestinal disorders revealed in patents

May 27, 2005

Par and Optimer enter development and collaboration agreement for PAR-101

May 27, 2005

PTCA shows therapeutic potential for NASH

May 27, 2005

HCV-796 moves into phase Ib trial in hepatitis C patients

May 26, 2005

Preclinical data on TZP-101, a novel GHS-R1a agonist, for the treatment of gastric motility disorder

May 26, 2005

STA-5326 shows potential for Crohn's disease

May 24, 2005

Fontolizumab reduces Crohn's disease activity in an open-label study

May 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...